Utah Medical Products, Inc. (UTMD) Revenue by Segment & Business Profile
Gynecology Electrosurgery Urology was 50.2% of Utah Medical Products, Inc.'s revenue across the 4 lines it reports, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 236.3M
- P/E TTM
- 22.6
- Dividend yield
- 1.7%
- 52-week
- —
- Next earnings
- 27 Oct, in 2 days
What the company does
Utah Medical Products, Inc. is a medical instruments & supplies company in the healthcare sector. In its SEC filings it reports 4 business lines: Gynecology Electrosurgery Urology (50%), Neonatal (22%), Blood Pressure Monitoring And Accessories (15%), Obstetrics (12%). Trailing twelve-month revenue: $36.1 million as of 2026-06-30.
Roles we read
from the filings, not the sector label- Medical consumables / supplies
Revenue by geography
latest quarter · company segment note| Region | Revenue | Share | y/y |
|---|---|---|---|
| Domestic Us | 5M | 60.6% | -11.9% |
| Outside Us | 3M | 39.4% | -17.7% |
Utah Medical Products, Inc. — questions
- What does Utah Medical Products, Inc. do?
- Utah Medical Products, Inc. is a medical instruments & supplies company in the healthcare sector. In its SEC filings it reports 4 business lines: Gynecology Electrosurgery Urology (50%), Neonatal (22%), Blood Pressure Monitoring And Accessories (15%), Obstetrics (12%). Trailing twelve-month revenue: $36.1 million as of 2026-06-30.
- How does Utah Medical Products, Inc. make money?
- By the lines it reports in its SEC filings: Gynecology Electrosurgery Urology 50.2%, Neonatal 22.5%, Blood Pressure Monitoring And Accessories 14.8%, Obstetrics 12.5% of revenue.
Every figure on this page comes from Utah Medical Products, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.